IVERIC bio

About:

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

Website: https://ivericbio.com

Top Investors: Hercules Capital, Sofinnova Investments, Novo Holdings, SV Health Investors, Silicon Valley Bank

Description:

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.

Total Funding Amount:

$858M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Princeton, New Jersey, United States

Founded Date:

2007-01-01

Founders:

Samir Patel

Number of Employees:

101-250

Last Funding Date:

2022-11-30

IPO Status:

Public

© 2025 bioDAO.ai